Target intelligence / Profile preview

Extracellular matrix and wound bed microenvironment (ECM/WBM)

Target
ECM/WBM
Molecular classification
Other
01

Overview

The extracellular matrix (ECM) and wound bed microenvironment constitute a complex biological system providing structural scaffolding and biochemical cues necessary for tissue regeneration (StatPearls, 2023). The ECM is composed of fibrous proteins like collagen and elastin, alongside glycosaminoglycans and proteoglycans, which collectively regulate cell adhesion and signaling (NCBI, 2022). In chronic wounds, this microenvironment is often characterized by excessive proteolysis, hypoxia, and a persistent inflammatory state that prevents normal healing (PubMed, 2021). Therapeutic strategies target this environment through wound bed preparation, utilizing enzymatic debriders like collagenase to remove non-viable tissue or advanced dressings to modulate moisture and pH (Journal of Wound Care, 2020). Additionally, recombinant growth factors such as becaplermin are applied to stimulate cellular proliferation within the matrix (FDA, 2022). Effective management of the wound bed microenvironment is essential for transitioning stalled wounds into a productive healing phase and preventing complications like fibrosis or infection.

Other names
Wound microenvironmentExtracellular matrixGranulation tissueWound bedTissue microenvironment
02

Mechanism of action

Modulation of the wound environment through enzymatic debridement of necrotic tissue, restoration of structural integrity with scaffold substitutes, and biochemical stimulation of cellular pathways to promote the transition from inflammation to tissue remodeling.

03

Biological functions

Structural supportCell signalingTissue repairCell adhesionGrowth factor sequestrationMechanotransduction
04

Disease associations

Chronic woundsFibrosisDiabetic foot ulcerHypertrophic scarringCancerPressure ulcers
05

Safety considerations

Systemic absorption of topical agentsExcessive granulation tissue (proud flesh)Risk of secondary infectionPotential for fibrosis or keloid formationAllergic contact dermatitis to dressing components
06

Interacting drugs

Collagenase clostridium histolyticum

5 more in the full profile.

07

Biomarkers

Matrix metalloproteinase-9 (MMP-9)Tissue inhibitor of metalloproteinases (TIMP)LactateWound fluid pHC-reactive protein (CRP)Vascular endothelial growth factor (VEGF)

Beyond the preview

Go deeper on Extracellular matrix and wound bed microenvironment (ECM/WBM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix and wound bed microenvironment (ECM/WBM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call